Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
iCAN science seminar on May 23 with Prof. Catherine Wu
You are warmly welcome to iCAN science seminar on Thu 23.5.2024 at 13:30-14:30, Biomedicum 1, Seminar room 3 and online. Speaker: Prof. Catherine…
New study offers insights for optimizing CML treatment
Chronic Myeloid Leukemia (CML) is a disease more common in the elderly, marked by the excessive growth of immature white…
iCAN National Program strengthens profiling, data sharing, and biobanking in Finland
iCAN reached one of its important milestones at the end of 2023, when an agreement was signed between the universities…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding